3rd week on tirzepatide 3 update of taking (GLP-1) for my chronic pain & chronic inflammation with suspicions of diaphragmatic endometriosis (already diagnosed with Lyme disease, thoracic outlet syndrome & Tirzepatide Injections for Medical Weight

Anti-inflammatory and Antifibrotic Effects Chronic inflammation and myocardial fibrosis are hallmarks of HF progression

The Rebound Effect One of the most widely reported outcomes of discontinuing GLP-1 and GIP receptor agonists like tirzepatide is significant weight regain

Results: Early GLP-1 RA use demonstrated a modest but significant association with reduced overall cancer risk (HR 0.93

Goodfriend TL, Ball DL, Oelkers W, Bahr V

Our specialists are there to help you navigate these nutritional questions 24/7, ensuring you never feel like youre doing this alone

The first step is an online consultation with a seasoned healthcare provider who will custom-design your treatment plan according to your unique health goals